D 69 (Didanosine Delayed Release 200 mg)
Pill with imprint D 69 is White, Capsule-shape and has been identified as Didanosine Delayed Release 200 mg. It is supplied by Aurobindo Pharma.
Didanosine is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D 69
Didanosine Delayed Release
- Imprint
- D 69
- Strength
- 200 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- National Drug Code (NDC)
- 65862-0311
- Inactive Ingredients
-
sodium starch glycolate type A potato,
carboxymethylcellulose sodium,
sodium lauryl sulfate,
hypromellose 2910 (3 mPa.s),
magnesium silicate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
diethyl phthalate,
silicon dioxide,
gelatin,
titanium dioxide,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Related Images for "D 69"
More about didanosine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Patient Information
- Didanosine (Advanced Reading)
- Didanosine Delayed-Release Enteric-Coated Capsules
- Didanosine Oral Solution
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.